Haioun, C., Mounier, N., Emile, J. F., Ranta, D., Coiffier, B., Tilly, H., ...
Background: This study compared the induction regimens doxorubicin, cyclophosphamide and etoposide (ACE) with doxorubicin, cyclophosphamide, vincristine, bleomycin and prednisone (ACVBP) before...
Raynaud, C. M., Jang, S. J., Nuciforo, P., Lantuejoul, S., Brambilla, E., Mounier, N., ...
Background: A relation between telomere attrition in early carcinogenesis and activation of DNA damage response (DDR) has been proposed. We explored telomere length and its link with DDR in...
Morel, P., Gaulard, P., Gisselbrecht, C., Ferme, C., Salles, G., Tilly, H., ...
Background: Overexpression of B-cell lymphoma 2 (bcl-2) protein is a simple biological adverse prognostic factor that could delimit the poor prognosis population candidate for improvement with...
E Foïs, M Desmartin, S Benhamida, F Xavier, V Vanneaux, D Rea, ...
Bonnet, Christophe, Fillet, Georges, Mounier, N, Ganem, G, Molina, TJ, Thieblemont, C, ...
Purpose Chemoradiotherapy has been considered standard treatment for patients with limited-stage aggressive lymphoma on the basis of trials conducted before the introduction of the International...
Managing large cell lymphoma (2006)
Rituximab has greatly improved standard cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) chemotherapy, but prospects remain poor in patients with adverse risk factors. We need to know...
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma (2005)
REYES, F, LEPAGE, E, GANEM, G, MOLINA, TJ, BRICE, P, COIFFIER, B, ...
Mounier, N., Gisselbrecht, C., Brière, J., Haioun, C., Feugier, P., Offner, F., ...
Background: Data are still conflicting on the indication of front-line autologous stem-cell transplantation (ASCT) as consolidation for aggressive lymphoma. To assess the therapeutic effect of ASCT...
Fermé, C., Mounier, N., Diviné, M.
Background: The optimal treatment for patients with advanced Hodgkin's disease (HD) responding to initial chemotherapy (CT) and an intensive salvage therapy for those who fail to respond...
Haioun, C., Mounier, N., Quesnel, B., Morel, P., Rieux, C., Beaujean, F., ...
Purpose: In the previous LNH87-2 study, consolidative high-dose therapy followed by stem cell transplantation (HDT) improved disease-free survival, as well as survival for patients (pts) presenting...
Substantial progress has been made in understanding the role of autotransplantion in aggressivenon-Hodgkin's lymphoma. At present, the clinical indications for high-dose therapy include patients with...